QTTB Q32 Bio Inc.

$11.89 -8.36%

Healthcare · Pharmaceutical Preparations

Q32 Bio Inc. (QTTB) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $202 million. Shares last traded at $11.89, 19.5% below their 52-week high. Over the past year the stock is up 634.0%. QTTB trades at a price-to-earnings ratio of 6.77, below the Pharmaceutical Preparations median of 16.82. Net profit margin is 55.5%, above the peer median of -0.1%.

Market Cap

$202M

Shares Out

17.0M

EPS (TTM)

$-5.41

P/E Ratio

6.77

P/S Ratio

3.75

P/B Ratio

4.35

Dividend / Share

—

Dividend Yield

—

52-Week High

$14.77

52-Week Low

$1.34

Volume

13,688

Avg Vol (3m)

23,337.397

Performance

-5.93%

+97.18%

+78.93%

+314.29%

YTD

+246.65%

+633.95%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

57.80

SMA (50)

$7.99

SMA (200)

$4.68

Price vs SMA50

+48.82%

Price vs SMA200

+153.98%

ATR (14)

$1.23

Financials

Revenue

$54M

Net Income

$30M

Gross Margin

—

Operating Margin

31.5%

Net Margin

55.5%

Return on Equity

64.3%

Return on Assets

46.8%

Current Ratio

5.36

Debt / Equity

0.37

Revenue Growth (YoY)

—

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.54	2026-05-05
FY 2025	$2.42	2026-03-10
Q3 2025	$-2.29	2025-11-13
Q2 2025	$-1.68	2025-08-06
Q1 2026	$-0.90	2026-05-05
FY 2025	$-6.58	2026-03-10

Full earnings history →

Pharmaceutical Preparations peers

QTTB vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

6.77 / 16.82 med

-60% discount

P/S vs peers

3.75 / 3.54 med

+6% premium

Net margin vs peers

55.5% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.